Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2026-01-03 @ 3:23 AM
Study NCT ID:
NCT04493151
Status:
COMPLETED
Last Update Posted:
2024-08-07
First Post:
2020-07-27
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Imipenem/Cilastatin/Relebactam PK in ECMO
Sponsor:
Joseph L. Kuti, PharmD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
59752
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |